These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
912 related items for PubMed ID: 25387058
1. SWI/SNF chromatin remodeling and human malignancies. Masliah-Planchon J, Bièche I, Guinebretière JM, Bourdeaut F, Delattre O. Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058 [Abstract] [Full Text] [Related]
2. BAFfling pathologies: Alterations of BAF complexes in cancer. Arnaud O, Le Loarer F, Tirode F. Cancer Lett; 2018 Apr 10; 419():266-279. PubMed ID: 29374542 [Abstract] [Full Text] [Related]
3. Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors. Kuwahara Y, Iehara T, Matsumoto A, Okuda T. Cancer Med; 2023 Aug 10; 12(15):16323-16336. PubMed ID: 37317642 [Abstract] [Full Text] [Related]
4. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex. Sen P, Luo J, Hada A, Hailu SG, Dechassa ML, Persinger J, Brahma S, Paul S, Ranish J, Bartholomew B. Cell Rep; 2017 Feb 28; 18(9):2135-2147. PubMed ID: 28249160 [Abstract] [Full Text] [Related]
9. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer. Oike T, Ogiwara H, Nakano T, Yokota J, Kohno T. Jpn J Clin Oncol; 2013 Sep 23; 43(9):849-55. PubMed ID: 23904343 [Abstract] [Full Text] [Related]
10. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours. Rao Q, Xia QY, Wang ZY, Li L, Shen Q, Shi SS, Wang X, Liu B, Wang YF, Shi QL, Ma HH, Lu ZF, He Y, Zhang RS, Yu B, Zhou XJ. Histopathology; 2015 Jul 23; 67(1):121-9. PubMed ID: 25496315 [Abstract] [Full Text] [Related]
13. PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression. Mittal P, Myers JA, Carter RD, Radko-Juettner S, Malone HA, Rosikiewicz W, Robertson AN, Zhu Z, Narayanan IV, Hansen BS, Parrish M, Bhanu NV, Mobley RJ, Rehg JE, Xu B, Drosos Y, Pruett-Miller SM, Ljungman M, Garcia BA, Wu G, Partridge JF, Roberts CWM. Nat Commun; 2024 Aug 24; 15(1):7303. PubMed ID: 39181868 [Abstract] [Full Text] [Related]
14. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Kim KH, Roberts CW. Cancer Genet; 2014 Sep 24; 207(9):365-72. PubMed ID: 24853101 [Abstract] [Full Text] [Related]
15. THE COMPOSITION OF SWI/SNF CHROMATIN REMODELING COMPLEX IS STABLE DURING GENE TRANSCRIPTION. Mazina MY, Kocheryzhkina EV, Derevyanko PK, Vorobyeva NE. Tsitologiia; 2016 Sep 24; 58(4):285-9. PubMed ID: 30191696 [Abstract] [Full Text] [Related]
16. [Chromatin remodeling defects and cancer: the SWI/SNF example]. Bourdeaut F, Bièche I. Bull Cancer; 2012 Dec 24; 99(12):1133-40. PubMed ID: 23222069 [Abstract] [Full Text] [Related]
17. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. Shain AH, Pollack JR. PLoS One; 2013 Dec 24; 8(1):e55119. PubMed ID: 23355908 [Abstract] [Full Text] [Related]
18. SWI/SNF chromatin remodeling complexes and cancer. Biegel JA, Busse TM, Weissman BE. Am J Med Genet C Semin Med Genet; 2014 Sep 24; 166C(3):350-66. PubMed ID: 25169151 [Abstract] [Full Text] [Related]
19. Chromatin remodellers as therapeutic targets. Malone HA, Roberts CWM. Nat Rev Drug Discov; 2024 Sep 24; 23(9):661-681. PubMed ID: 39014081 [Abstract] [Full Text] [Related]
20. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities. Orlando KA, Nguyen V, Raab JR, Walhart T, Weissman BE. Expert Rev Anticancer Ther; 2019 May 24; 19(5):375-391. PubMed ID: 30986130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]